PALLIATIVE RADIATION DURING PEMETREXED PLUS CISPLATIN FIRST-LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PATIENT SAFETY IN THE JMDB AND PARAMOUNT TRIALS

被引：0
|
作者：
Scagliotti, G. V. [1 ]
Gridelli, C. [2 ]
de Marinis, F. [3 ]
Biesma, B. [4 ]
Reck, M. [5 ]
San Antonio, B. [6 ]
Zimmermann, A. H. [7 ]
Visseren-Grul, C. [8 ]
Chouaki, N. [9 ]
Paz-Ares, L. [10 ]
机构：
[1] Univ Turin, Turin, Italy
[2] San Giuseppe Moscati Hosp, Dept Oncol Hematol, Avellino, Italy
[3] San Camillo Forlanini Hosp, Oncol Pulm Unit 1, Rome, Italy
[4] Jeroen Bosch Hosp, Dept Pulm Dis, sHertogenbosch, Netherlands
[5] Hosp Grosshansdorf, Grosshansdorf, Germany
[6] Eli Lilly & Co, Oncol, Madrid, Spain
[7] Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA
[8] Eli Lilly & Co, Oncol Thorac, Houten, Netherlands
[9] Eli Lilly & Co, Oncol Thorac, Paris, France
[10] Seville Univ Hosp, Seville, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113P
引用
下载
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [21] Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Li, Ming
    Zhang, Qian
    Fu, Peifang
    Li, Ping
    Peng, Aimei
    Zhang, Guoliang
    Song, Xiaolian
    Tan, Min
    Li, Xuan
    Liu, Yang
    Wu, Yueping
    Fan, Suyun
    Wang, Changhui
    PLOS ONE, 2012, 7 (05):
  • [22] Meta-analysis of pemetrexed (P) plus gemcitabine (G) in first-line, advanced (adv) non-small cell lung cancer (NSCLC)
    Ye, Z.
    Treat, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [24] A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC)
    Letsa, I.
    Mikropoulos, C.
    Burcombe, R.
    Visioli, A.
    Sevitt, T.
    Cominos, M.
    Beesley, S.
    LUNG CANCER, 2011, 71 : S7 - S7
  • [25] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [26] First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.
    Bobilev, D
    Ariad, S
    Geffen, DB
    Cohen, Y
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [27] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
    Chang, John Wen-Cheng
    Thongprasert, Sumitra
    Wright, Elaine
    Tsang, Kenneth
    Kim, Heung Tae
    Ahn, Myung-Ju
    Kim, Joo-Hang
    Kang, Jin Hyoung
    Kim, Sang-We
    Walzer, Stefan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21
  • [28] Safety Data Analyses for First-Line Pemetrexed Plus Carboplatin (Pem plus Cb) in Nonsquamous Non-Small Cell Lung Cancer (ns-NSCLC)
    Okamoto, I.
    Schuette, W.
    Stinchcombe, T.
    Rodrigues Pereira, J.
    Liu, J.
    San Antonio, B.
    John, W.
    Chen, J.
    Zinner, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S22 - S23
  • [29] S-1 plus cisplatin as first-line treatment of patients with advanced non-small cell lung cancer in Taiwan
    Lai, Chun-Liang
    Wei, Yu-Fen
    Hsia, Te-Chun
    Chang, Gee-Chen
    Wu, Jiun-Ting
    Chen, Jung-Yueh
    Chen, Yuh-Min
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (02) : E68 - E73
  • [30] Clinical Observation and Prognostic Analysis of Pemetrexed plus Platinum as First-line Treatment in Patients with Advanced Non-small Cell Lung Cancer
    Wang, Ji-Ying
    Cai, Yong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6267 - 6271
12345